SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Biocryst Pharmaceuticals Q3 EPS $(0.34) Down From $(0.28) YoY, Sales $1.775M Up From $1.454M YoY

Biocryst Pharmaceuticals (NASDAQ:BCRX) reported quarterly losses of $(0.34) per share. This is a 21.43 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $1.775

Benzinga · -

Biocryst Pharmaceuticals (NASDAQ:BCRX) reported quarterly losses of $(0.34) per share. This is a 21.43 percent decrease over losses of $(0.28) per share from the same period last year. The company reported $1.775 million in sales this quarter. This is a 22.08 percent increase over sales of $1.454 million the same period last year.